Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1995 Jun;162(6):548–551.

Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda.

A C Liu 1
PMCID: PMC1022841  PMID: 7618323

Full text

PDF
548

Images in this article

548Image
on p.548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berman L. B. When the urine is red. JAMA. 1977 Jun 20;237(25):2753–2754. [PubMed] [Google Scholar]
  2. Cohen P. R., Suarez S. M., DeLeo V. A. Porphyria cutanea tarda in human immunodeficiency virus-infected patients. JAMA. 1990 Sep 12;264(10):1315–1316. doi: 10.1001/jama.264.10.1315. [DOI] [PubMed] [Google Scholar]
  3. DAVIS M. J., PLOEG D. E. V. Acute porphyria and coproporphyrinuria following chloroquine therapy; a report of two cases. AMA Arch Derm. 1957 Jun;75(6):769–800. [PubMed] [Google Scholar]
  4. Drasch G., Eisenmenger W. Tod nach Gabe von 1,250 mg Chloroquin bei Porphyria cutanea tarda. Z Rechtsmed. 1986;97(4):285–293. doi: 10.1007/BF00200608. [DOI] [PubMed] [Google Scholar]
  5. Elder G. H. The cutaneous porphyrias. Semin Dermatol. 1990 Mar;9(1):63–69. [PubMed] [Google Scholar]
  6. Fargion S., Piperno A., Cappellini M. D., Sampietro M., Fracanzani A. L., Romano R., Caldarelli R., Marcelli R., Vecchi L., Fiorelli G. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992 Dec;16(6):1322–1326. doi: 10.1002/hep.1840160603. [DOI] [PubMed] [Google Scholar]
  7. Felsher B. F., Redeker A. G. Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda. Medicine (Baltimore) 1966 Nov;45(6):575–583. doi: 10.1097/00005792-196645060-00024. [DOI] [PubMed] [Google Scholar]
  8. Grossman M. E., Bickers D. R., Poh-Fitzpatrick M. B., Deleo V. A., Harber L. C. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med. 1979 Aug;67(2):277–286. doi: 10.1016/0002-9343(79)90403-0. [DOI] [PubMed] [Google Scholar]
  9. Grossman M. E., Poh-Fitzpatrick M. B. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias. Dermatol Clin. 1986 Apr;4(2):297–309. [PubMed] [Google Scholar]
  10. Harber L. C., Bickers D. R. Porphyria and pseudoporphyria. J Invest Dermatol. 1984 Mar;82(3):207–209. doi: 10.1111/1523-1747.ep12259984. [DOI] [PubMed] [Google Scholar]
  11. LINDEN I. H., STEFFEN C. G., NEWCOMER V. D., CHAPMAN M. Development of porphyria during chloroquine therapy for chronic discoid lupus erythematosus. Calif Med. 1954 Sep;81(3):235–238. [PMC free article] [PubMed] [Google Scholar]
  12. MARSDEN C. W. Porphyria during chloroquine therapy. Br J Dermatol. 1959 Jun;71(6):219–222. doi: 10.1111/j.1365-2133.1959.tb13411.x. [DOI] [PubMed] [Google Scholar]
  13. Parodi A., Guarrera M., Rebora A. Amiodarone-induced pseudoporphyria. Photodermatol. 1988 Jun;5(3):146–147. [PubMed] [Google Scholar]
  14. Poh-Fitzpatrick M. B. Porphyria, pseudoporphyria, pseudopseudoporphyria...? Arch Dermatol. 1986 Apr;122(4):403–404. [PubMed] [Google Scholar]
  15. Scholnick P. L., Epstein J., Marver H. S. The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol. 1973 Oct;61(4):226–232. doi: 10.1111/1523-1747.ep12676478. [DOI] [PubMed] [Google Scholar]
  16. Stenberg A. Pseudoporphyria and sunbeds. Acta Derm Venereol. 1990;70(4):354–356. [PubMed] [Google Scholar]
  17. Topi G. C., Amantea A., Griso D. Recovery from porphyria cutanea tarda with no specific therapy other than avoidance of hepatic toxins. Br J Dermatol. 1984 Jul;111(1):75–82. doi: 10.1111/j.1365-2133.1984.tb04019.x. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES